Withdrawal of Long-Term Cabergoline Therapy for Tumoral and Nontumoral Hyperprolactinemia
Annamaria Colao(Federico II University Hospital), Gaetano Lombardi(University of Genoa), Rosario Pivonello(University of Naples Federico II), Paolo Cappabianca(Federico II University Hospital), Carolina Di Somma(University of Naples Federico II), Antonella Di Sarno(Molecular Oncology (United States))
Cited by 336
Related Papers
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
|Endocrine Reviews|2004|1.3k
Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas
|Clinical Endocrinology|2006|830
Guidelines for Acromegaly Management: An Update
|The Journal of Clinical Endocrinology & Metabolism|2009|763
Complications of Cushing's syndrome: state of the art
|The Lancet Diabetes & Endocrinology|2016|602
Nutritional recommendations for CoVID-19 quarantine
|European Journal of Clinical Nutrition|2020|548